Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins
Features & Benefits
Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro
Precise and effective
- Tests for both IgM and IgG antibodies
- Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94%
- ->92% total accuracy: IgG 96,5% - IgM: 92,8%
- High reproducibility (consistent results across the same patient)
-
High quality, reliable & convenient
- Single-prick blood test
- 10-15 minutes per test
- Intuitive visual interpretation
- No specialized training or equipment needed
- Portable hence highly scalable
- Storage at room temperature (2-30 C)
- Conformance to CE (Europe) and ISO manufacturing
The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings
SUSTAINABLE QUALITY
Validated Declaration of CE conformity
- Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors
- Under process for receiving USDA E authorization
Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium)
- One of the very lew players manufacturing in Europe, with zero complaints also certified locations
ACCEPTABILITY ACROSS MARKETS
Demonstrated capabilities in local countries validation
- Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product
Participated in published research
- Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit
PROVEN COMMERCIAL EXPERIENCE
Sold in 25+ countries already
- Including Europe, US, Canada, Africa and multiple developed and emerging markets
- Under participation in govt tenders
Robust manufacturing capability and capacity
- ISO-certified manufacturing site
- Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability
AFFORDABLE AND SCALABLE
Viable to scale up at Institutions and Retail level
- Economical cost per-unit established over many months of process improvement and local manufacturing
- Can cater to insured as well as out-of pocket populations
Continuous improvement through R&D
- Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada
- Other platforms including Rapid antigen testing also being developed
The price is per unit, the minimum is 25000 units
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing. 1.Easy to collect samples simple operation without professional equipment. 2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy. 4.Suitable for large-scale rapid screening. Shelf life: 24 Months Test Result time: 10 Mins Packing: 25 Pieces per Box
FAST: Results in under 2 minutes ACCURATE: 99.9% specificity and 98.7% sensitivity EASY TO USE: Convenient for testing at home PAINLESS: Simple and painless saliva collection RELIABLE: 24-Hour RT-PCR Confirmation (100% specific and 100% sensitive) 99.9% specificity. Test specificity this high ensures that almost all the people who are not infected get a negative test result with the Sensiva React Rapid Covid-19 Testing Kit. Using a fast and accurate test such as this one is vital when we are trying to stop virus transmission and protect general health. 98.7% sensitivity Test sensitivity refers to the percentage of infected people who get a positive test result. In our case that means that 98.7% of people with an infection get a positive test result. How to use it? Step 1 â?? Do the test Sensiva React Rapid Test is a simple test that can be� easily done at home. It is convenient and� painless� since it requires you to collect a saliva sample instead of a nasal swab. How to do it? First, use the mobile application to scan the QR code to register. After that, collect a saliva sample and add it into the saliva hole in the reader device before adding the liquid solution. You will be able to interpret your� results in under 2 minutes. Watch a video with detailed instructions on how to do the test in the video below. Please follow the instructions carefully to obtain a valid test result. Step 2 â?? Get RT-PCR confirmation in 24 hours You can use the prepaid shipping label and send the saliva sample used for the rapid test to us. You will get an official PCR result (100% sensitivity and 100% specificity) in 24 hours. Our lab is certified under the Clinical Laboratory Improvement Amendments (CLIA), so you can rely on us to provide you with accurate and reliable test results. Who is Sensiva React Rapid Covid-19 Test for? Sensiva React Rapid Covid-19 Test is designed for patients with COVID-19 symptoms or those who are asymptomatic but suspected of having exposure. Its easy-to-follow instructions make it convenient for testing at home. The kit contains: (1) Specimen Tube (1) Saliva Funnel (1) Dropper (1) Bio-hazard bag with absorbent pad (1) Lateral flow device (1) 5ml EZ-Tear Saline Solution (1) 0.3ml EZ-Tear Buffer Solution (1) Written Instruction Card
PANODYNE - The new rapid lgM-lgG combined antibody test* for COVID-19 from Multibrands International is now available to test for the detection of lgG and lgM antibodies of coronavirus from a small specimen of human serum, plasma or whole blood. The detection works with proteins to indicate if a person's immune system has responded with the COVID-19 virus to indicate infection.
Covid -19 Test Kit (Colloidal Gold Method) For Self-testing Use (Nasal Swab) Top 10 In China Having Ce Mark For Rapid Covid - 19 Antigen Self-test Precise Rapid Sensitive For At-home Testing For Early Detection Able To Sell Across All Eu Member States
Rapid Tests Kits OTG USA COVID-19 Rapid Urine Antibody Test (World's First and Only) COVID-19 IgG / IgM Rapid Antibody Detection Test COVID-19 Saliva Antigen Rapid POC Test COVID-19 Antigen Rapid POC Test (Nasal Swab Collection)
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals. This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This product is intended for professional use and not for home use. FACT SHEET FOR HEALTHCARE PROVIDERS This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
We supply various brands of Antigen Saliva and Nose test kit
Antibody Test Kits Hot Sale Medical Diagnostic Antigen Antibody Rapid Test Kits
Cat. No : 5513C. COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
